The implications of this work for significant from a number of pathological perspectives. Human blinding conditions such as glaucoma, potentially ischemic optic neuropathy (though there is considerable debate there) and certainly optic nerve trauma are all diseases or pathological insults that involve ganglion cell loss in those patients. Being able to slow down, prolong or prevent ganglion cell death in disorders where they can be compromised can lead to preservation of vision.